Excellus' dramatic rise in operating losses
Excellus BlueCross BlueShield attributes the drop to "significant increases in the cost and demand for health care," with rising drug and medical costs resulting in a $200 million loss across its Medicare Advantage products.
A graph show a blue line dropping from left to right from a a $227 million net positive to a $162 million in the negative.
